CASSIDY CRAWFORD: Open Payments
NPI 1952017881 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,342 in 65 payments from 17 companies in 2025. Trend: 2023 $846 · 2024 $1,501 · 2025 $1,342
Food & beverage: $1,342
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $228 |
| PFIZER INC. | 9 | $213 |
| Astellas Pharma US Inc | 6 | $169 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $112 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| ABBVIE INC. | 4 | $74 |
| Exact Sciences Corporation | 4 | $65 |
| Lilly USA, LLC | 3 | $52 |
Products named: Veozah, NURTEC ODT, Wegovy, Kerendia, CAPLYTA, REXULTI, SHINGRIX, Ozempic.
Industry payments across TN — which companies pay providers there.
